Charles River Laboratories International (CRL) Long-Term Deferred Tax (2010 - 2026)

Charles River Laboratories International has reported Long-Term Deferred Tax for 17 years, with the latest figure at $53.8 million in Q2 2026.

• On a quarterly basis, Long-Term Deferred Tax rose 14.66% year-over-year to $53.8 million in Q2 2026; TTM through Jun 2026 was $53.8 million, a 14.66% increase from a year earlier, with the FY2025 full-year figure at $67.3 million, up 59.64% from the prior year.
• Long-Term Deferred Tax was $53.8 million for Q2 2026 at Charles River Laboratories International, down from $88.6 million in the prior quarter.
• The five-year high for Long-Term Deferred Tax was $88.6 million in Q1 2026, with the low at $34.3 million in Q3 2023.
• Average Long-Term Deferred Tax over 5 years is $45.4 million, with a median of $41.1 million recorded in 2022.
• The sharpest annual moves came in 2023 and 2026: Long-Term Deferred Tax retreated 13.74% in 2023, then jumped 81.58% in 2026.
• Over 5 years, Long-Term Deferred Tax stood at $41.3 million in 2022, then slipped by 2.38% to $40.3 million in 2023, then climbed by 4.72% to $42.2 million in 2024, then soared by 59.64% to $67.3 million in 2025, then retreated by 20.06% to $53.8 million in 2026.
• The last three Long-Term Deferred Tax figures came in at $53.8 million (Q2 2026), $88.6 million (Q1 2026), and $67.3 million (Q4 2025), per Business Quant data.